Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
Clinical trial NCT04009967 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04009967
- Sponsor
- CHU de Quebec-Universite Laval
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2024-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.